Researcher Claims Bayer's Inaction Cost Lives

Law360, New York (February 19, 2008, 12:00 AM EST) -- An estimated 22,000 lives could have been saved if Bayer AG had come clean with the U.S. Food and Drug Administration about the potentially fatal problems connected to its blood-clotting drug Trasylol, a researcher has alleged in a new report airing on "60 Minutes."

Dr. Dennis Mangano is claiming that thousands of people might not have died if Bayer had been honest with the agency about the results of a January 2006 study he conducted on behalf of the pharmaceutical giant, which revealed widespread problems with...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.